| Cat.No. | Name | Information |
|---|---|---|
| M10249 | Teduglutide | Teduglutide is a glucagon-like peptide-2 (GLP-2) analogue used for the treatment of short-bowel syndrome. |
| M53160 | (Asp28)-Exenatide | (Asp28)-Exenatide is a degradation product of exenatide. |
| M53159 | GLP-1 (1-36) amide (human, rat) | GLP-1 (1-36) amide (human, rat) (Glucagon-like Peptide 1 (1-36) amide (human, rat) ) is a molecular variant of glucagon-like peptide 1 (GLP-1)-(7-36) amide. |
| M53158 | Albiglutide fragment | Albiglutide fragment (GLP-1 (7-36) analog) is an active fragment of Albiglutide (7-36) and a glucagon-like peptide-1 (GLP-1) analog (a long-acting GLP-1 receptor agonist). |
| M53157 | Pegloxenatide | Pegloxenatide is a glucagon-like peptide-1 receptor (GLP-1 RA) agonist. |
| M49443 | Maridebart cafraglutide | Maridebart cafraglutide is a peptide-coupled compound (PDC), as well as a GIPR antagonist and a GLP-1R agonist, which can be used in studies related to type 2 diabetes. |
| M45220 | PF-06954522 | PF-06954522 is an orally active small molecule GLP-1 agonist for studies related to metabolic diseases. |
| M45168 | CT-388 | CT-388 is a dual GLP-1/GIP receptor modulator that can be used in studies related to type 2 diabetes. |
| M41838 | GLP-1 receptor agonist 12 | GLP-1 receptor agonist 12 is an agonist of GLP Receptor. |
| M41837 | GLP-1 receptor agonist 11 | GLP-1 receptor agonist 11 is an agonist of GLP Receptor. |
| M41836 | GLP-1 receptor agonist 10 | GLP-1 receptor agonist 10 is an agonist of GLP Receptor. |
| M41835 | GLP-1 receptor agonist 13 | GLP-1 receptor agonist 13 is a glucagon GLP-1 receptor agonist with EC50 of 76 nM. |
| M41832 | LSN3160440 | LSN3160440 is an allosteric modulator of GLP-1R, which acts as a protein–protein interaction (PPI) stabilizer or molecular glue to assist in the adhesion of inactive GLP-1 (9-36) NH2 on GLP-1R. |
| M41828 | GIP/GLP-1 dual receptor agonist-1 | GIP/GLP-1 dual receptor agonist-1 is a GIP/GLP-1 receptor agonist. |
| M41825 | VU0453379 hydrochloride | VU0453379 hydrochloride is a highly selective and central nervous system (CNS) penetrant positive allosteric modulator (PAM) of glucagon-like peptide-1R (GLP-1R) with an EC50 of 1.3 μM. |
| M40712 | K-833 | K-833 is a GLP-1R modulator that can be used in studies related to type 2 diabetes and obesity. |
| M40710 | RGT-075 | RGT-075 is a GLP-1R modulator that can be used in studies related to metabolic diseases as well as type 2 diabetes. |
| M40709 | GSBR-1290 | GSBR-1290 is a GLP-1R agonist that can be used in studies related to type 2 diabetes and obesity. |
| M40591 | Vurolenatide | Vurolenatide is a compound that acts on the GLP-1 receptor and may be used in studies related to short bowel syndrome. |
| M40590 | Pegsebrenatide | Pegsebrenatide is a compound that acts on GLP-1R. |
| M40589 | Froniglutide | Froniglutide is a GLP-1R-acting compound that increases muscle mass and strength by targeting GLP-1 receptors that are overexpressed in muscle, thereby acting directly on muscle cells. It can be used in studies related to dermatomyositis / polymyositis (DM / PM). |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
